315 related articles for article (PubMed ID: 8194526)
1. c-Abl kinase regulates the protein binding activity of c-Crk.
Feller SM; Knudsen B; Hanafusa H
EMBO J; 1994 May; 13(10):2341-51. PubMed ID: 8194526
[TBL] [Abstract][Full Text] [Related]
2. Crk family adaptor proteins trans-activate c-Abl kinase.
Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
[TBL] [Abstract][Full Text] [Related]
3. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren R; Ye ZS; Baltimore D
Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
[TBL] [Abstract][Full Text] [Related]
4. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
5. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Ribon V; Hubbell S; Herrera R; Saltiel AR
Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
[TBL] [Abstract][Full Text] [Related]
6. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
8. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
[TBL] [Abstract][Full Text] [Related]
9. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
[TBL] [Abstract][Full Text] [Related]
11. Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteins.
Khwaja A; Hallberg B; Warne PH; Downward J
Oncogene; 1996 Jun; 12(12):2491-8. PubMed ID: 8700507
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
Sriram G; Reichman C; Tunceroglu A; Kaushal N; Saleh T; Machida K; Mayer B; Ge Q; Li J; Hornbeck P; Kalodimos CG; Birge RB
Oncogene; 2011 Nov; 30(46):4645-55. PubMed ID: 21602891
[TBL] [Abstract][Full Text] [Related]
13. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
Mayer BJ; Hirai H; Sakai R
Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
[TBL] [Abstract][Full Text] [Related]
14. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins.
Knudsen BS; Zheng J; Feller SM; Mayer JP; Burrell SK; Cowburn D; Hanafusa H
EMBO J; 1995 May; 14(10):2191-8. PubMed ID: 7774577
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
17. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
18. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
[TBL] [Abstract][Full Text] [Related]
19. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
20. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
Sabe H; Okada M; Nakagawa H; Hanafusa H
Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]